[1]
T. S. Humani, S. Sutari, T. Triningsih, M. Ramli, R. Ritawidya, and R. D. Haryuni, “Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment”, J. Math. Fund. Sci., vol. 49, no. 3, pp. 258-268, Dec. 2017.